Stacy Grieve, PhD,  —

Articles by Stacy Grieve

Synthetic Antimicrobial Peptide Can Destroy Biofilms in CF Patients, Study Reports

A therapy that involves a synthetic cationic antimicrobial peptide (CAP) can decrease Pseudomonas aeruginosa biofilm formation alone or in combination with another antimicrobial agent called tobramycin. Cystic fibrosis (CF) patients are susceptible to repeated bacterial infections. Infection with Pseudomonas aeruginosa (P. aeruginosa) is particularly harmful, since it has been shown to decrease…

Your CF Community


Visit the Cystic Fibrosis News Today forums to connect with others in the CF community.